Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 15/20 | 0.60 |
| ▸ | APP | P05067 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15326995 | 0.91 | ALDH1A1 (0.53) | GRM5APPCASP3ALDH1A1MEN1 | |
| SCHEMBL23980507 | 0.88 | APP (0.56) | GRM5APPALDH1A1MEN1MAPT | |
| SCHEMBL22242553 | 0.87 | GRM5 (0.54) | GRM5APP | |
| SCHEMBL10035484 | 0.84 | GRM5 (0.47) | GRM5APPCASP3ALDH1A1MEN1 | |
| SCHEMBL14326433 | 0.83 | GRM5 (0.56) | GRM5APP | |
| SCHEMBL21028319 | 0.82 | ALDH1A1 (0.49) | GRM5APPCASP3ALDH1A1MEN1 | |
| SCHEMBL504644 | 0.82 | GRM5 (0.60) | GRM5ALDH1A1MEN1KMT2AHSD17B10 | |
| SCHEMBL16927161 | 0.81 | GRM5 (0.54) | GRM5ALDH1A1MEN1KMT2AHSD17B10 | |
| SCHEMBL7678431 | 0.81 | ESR1 (0.58) | GRM5ALDH1A1MEN1KMT2A | |
| SCHEMBL14326160 | 0.81 | GRM5 (0.63) | GRM5MEN1MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037319-B2 | Curable compound | DAICEL CORPORATION (JP) | 2024-07-16 | — | — | US | disclosed |
| US-12037319-B2 | Curable compound | DAICEL CORPORATION (JP) | 2024-07-16 | — | — | US | disclosed |
| US-20240067777-A1 | CURABLE COMPOUND PRODUCT | DAICEL CORPORATION (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240067777-A1 | CURABLE COMPOUND PRODUCT | DAICEL CORPORATION (JP) | 2024-02-29 | — | — | US | disclosed |
| US-20240026076-A1 | CURABLE COMPOUND PRODUCT | DAICEL CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20240026076-A1 | CURABLE COMPOUND PRODUCT | DAICEL CORPORATION (JP) | 2024-01-25 | — | — | US | disclosed |
| US-20230373916-A1 | CURABLE COMPOUND PRODUCT | DAICEL CORPORATION (JP) | 2023-11-23 | — | — | US | disclosed |
| US-20230373916-A1 | CURABLE COMPOUND PRODUCT | DAICEL CORPORATION (JP) | 2023-11-23 | — | — | US | disclosed |
| US-20230260787-A1 | COMPOSITION FOR FORMING PROTECTIVE FILM AGAINST ALKALINE AQUEOUS HYDROGEN PEROXIDE, SUBSTRATE FOR PRODUCING SEMICONDUCTOR APPARATUS, METHOD FOR FORMING PROTECTIVE FILM, AND METHOD FOR FORMING PATTERN | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-08-17 | — | — | US | disclosed |
| US-11676814-B2 | Material for forming organic film, substrate for manufacturing semiconductor apparatus, method for forming organic film, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-06-13 | — | — | US | disclosed |
| EP-1994078-B1 | METHOD FOR HIGH DENSITY DATA STORAGE AND IMAGING | IBM (US) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008151184-A1 | BENZAMIDE MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME | VANDERBILT UNIVERSITY (US) | 2008-12-11 | — | — | WO | disclosed |
| WO-2008151184-A1 | BENZAMIDE MGLUR5 POSITIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING SAME | VANDERBILT UNIVERSITY (US) | 2008-12-11 | — | — | WO | disclosed |
| US-20080219135-A1 | METHOD FOR HIGH DENSITY DATA STORAGE AND IMAGING | GLOBALFOUNDRIES U.S. INC. | 2008-09-11 | — | — | US | disclosed |
| US-20080175135-A1 | DATA STORAGE MEDIUM AND METHOD FOR HIGH DENSITY DATA STORAGE | DUERIG URS T | 2008-07-24 | — | — | US | disclosed |
| US-20080076903-A1 | DATA STORAGE MEDIUM AND METHOD FOR HIGH DENSITY DATA STORAGE | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2008-03-27 | — | — | US | disclosed |
| WO-2007096359-A2 | METHOD FOR HIGH DENSITY DATA STORAGE AND IMAGING | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2007-08-30 | — | — | WO | disclosed |
| US-20070195682-A1 | METHOD FOR HIGH DENSITY DATA STORAGE AND IMAGING | GLOBALFOUNDRIES INC. (KY) | 2007-08-23 | — | — | US | disclosed |
| US-20070195682-A1 | METHOD FOR HIGH DENSITY DATA STORAGE AND IMAGING | GLOBALFOUNDRIES INC. (KY) | 2007-08-23 | — | — | US | disclosed |
| US-20070196645-A1 | Method for high density data storage and imaging | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2007-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12037319-B2 | Curable compound | CCT5, PGA5, KDM5B | GRM5 369/4885APP 3185/4885CASP3 1212/4885 |
| US-20230373916-A1 | CURABLE COMPOUND PRODUCT | RPLP0, SSRP1, RPP30 | GRM5 3344/4885APP 2210/4885CASP3 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.